This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies
Arum's research focuses on the discovery of new chemical entities that will act as effective therapies for drug-resistant cancers
The scope of supply includes the skid-mounted plant as well as on-site installation and commissioning support
The company plans to launch the product immediately
This pre-packaged release is a ready-to-go solution with powerful, straightforward bioanalysis pipeline support
The investment will accelerate the overall Sarclisa development program
Jointly fund and develop up to three antibody-drug conjugate programs for the treatment of cancer
MTBVAC is a global public-private project that will be a milestone in the field of vaccinology
Under the agreement, both companies will conduct collaborative research utilizing NuclixBio's proprietary circular mRNA platform named 'ringRNA’ to develop novel mRNA therapeutics that can generate PharmAbcine's antibodies
Use of Wipro Holmes Artificial Intelligence capabilities will lead to faster development of advanced therapeutics, improving patient outcomes
Subscribe To Our Newsletter & Stay Updated
